Award

Fairn recognized as ‘one of the most promising lipid researchers'

He won the ASBMB's 2017 Walter A. Shaw Young Investigator Award in Lipid Research
Adriana Bankston
April 1, 2017

Gregory Fairn, an assistant professor at the University of Toronto and staff scientist at St. Michael’s Hospital in Toronto, won the 2017 Walter A. Shaw Young Investigator Award in Lipid Research for his discoveries in the field of lipid biology.

Gregory Fairn “It is a great honor to be nominated for this award by colleagues and mentors who helped shape my career. Walt and Avanti Polar Lipids have been very active and supportive of lipid research over the years. I am truly humbled to receive the Walter Shaw Young Investigator Award. I’d like to thank ASBMB for the award, and the great mentors, colleagues, trainees and funding agencies for their work and support over the years.” — GREGORY FAIRN

In his letter supporting Fairn’s nomination for the award, David Byers at Dalhousie University said, “Greg Fairn has developed from one of the very best graduate students I have encountered to one of the most promising lipid researchers. He is rapidly becoming a leader in the lipid-research field not only through his scientific excellence and creativity but also by virtue of his positive attitude, collegiality and work ethic.”

Fairn’s career began in the lab of Christopher McMaster at Dalhousie University, where he investigated the regulation of lipid metabolism and vesicular transport in the trans-Golgi using yeast genetics. According to McMaster, who nominated Fairn for this award, Fairn “made a major breakthrough in our understanding of how cells target lipids and proteins to organelles within the cell.” During his graduate studies, he published 11 papers, six of them as first author.

Continuing his work in the field of lipid biochemistry during his postdoctoral studies, Fairn examined negatively charged lipids and “uncovered a critical role of these lipids in the regulation of cell polarization, phagocytosis and macropinocytosis,” said Vanina Zaremberg at the University of Calgary, who supported Fairn’s nomination for this award. During this time, Fairn became proficient in conducting studies of lipid biology in mammalian cells using biophysical techniques in the laboratory of Sergio Grinstein from the Hospital for Sick Children and the University of Toronto. Grinstein also supported Fairn’s nomination for the award. “While he learned virtually all we have to offer, I think we learned even more from him,” said Grinstein in his letter of support.

In his own laboratory at the University of Toronto since 2012, Fairn continues to “lead the lipid field with his pioneering discoveries on the interdependence of phosphatidylserine and cholesterol intracellular distribution and movement,” according to Zaremberg. His laboratory recently generated a fluorescent cholesterol sensor suitable for live-cell imaging and electron microscopy. The biosensor has “enormous potential and will surely become a widely used tool in the near future,” said Grinstein.

Fairn also has earned numerous awards attesting to his contributions to the field of lipid biochemistry, such as the Exceptional Trainee Award from the Hospital for Sick Children, a New Investigator Award from the Canadian Institutes for Health Research and an Early Research Award from the province of Ontario.

Fairn will receive his award during the 2017 ASBMB Annual Meeting in Chicago, where he will deliver an award lecture. The presentation will take place at 11:40 a.m. April 23 in room W183c in McCormick Place.

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Adriana Bankston

Adriana Bankston is a principal legislative analyst at the University of California Office of Federal Governmental Relations. She is also chief executive officer and managing publisher at the Journal of Science Policy and Governance. This post represents the writer's personal views and not the views of their employer.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

‘With advances in mass spectrometry, we can explore terra incognita’
Interview

‘With advances in mass spectrometry, we can explore terra incognita’

Sept. 29, 2022

A conversation with Molecular & Cellular Proteomics associate editor Albert Heck, a researcher at Utrecht University.

In memoriam: Clark Bublitz
In Memoriam

In memoriam: Clark Bublitz

Sept. 26, 2022

He was a metabolic enzymologist and a member of the American Society for Biochemistry and Molecular Biology since 1963.

Understanding protein dynamics to design better drugs
Research Spotlight

Understanding protein dynamics to design better drugs

Sept. 21, 2022

C. Denise Okafor is an assistant professor of biochemistry and molecular biology at Penn State and recipient of an NSF CAREER award.

Computation is the new experiment
Annual Meeting

Computation is the new experiment

Sept. 20, 2022

This symposium, Artificial Intelligence and Machine Learning in Structural Biology, Drug Design and Systems Biology. will be part of #DiscoverBMB 2023 in March.

Kuriyan to take over as dean;  Johnson wins Pew scholarship
Member News

Kuriyan to take over as dean; Johnson wins Pew scholarship

Sept. 19, 2022

Awards, promotions, milestones and more. Find out what's going on in the lives of ASBMB members.

'Keep developing your expertise'
Interview

'Keep developing your expertise'

Sept. 16, 2022

Anand Balakrishnan is a biochemist at Enanta Pharmaceuticals. He leads a team that has worked on respiratory syncytial virus, SARS-CoV-2 and hepatitis B virus.